Concerns around patient consent for genomic data

I’ve written a lot recently about the rise in genomic data, and the applications being developed on top of this.  For instance, a recent project featuring IBM and the New York Genome Center (NYGC), The Rockefeller University and other NYGC member institutions.

The work compared a number of techniques that are commonly used to analyze genomic data from tumor cells and healthy cells.  It utilized Watson for Genomics technology to help interpret the genome data.  The project revealed that Watson was able to provide actionable insights in just 10 minute, which compares to approximately 160 hours of human analysis.

Further evidence of the growing importance of genomic data comes via a partnership between the UK Biobank and the European Genome–phenome Archive (EGA), which is itself a joint resource developed by EMBL-EBI and the Centre for Genomic Regulation (CRG).

Read the full story by

Tags:

RELATED READS
Managers failing to grasp what their customers think How Slot Machines Can Help With HIV Testing
We are updating our Privacy Policy, so please make sure you take a minute to review it. As of May 25, 2018 your continued use of our services will be subject to this new Privacy Policy.
Review Privacy Policy OK